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Abstract: The expression of the phospholipase A2 activity (aiPLA2) of peroxiredoxin 6 (Prdx6) in the
cell cytoplasm is physiologically relevant for the repair of peroxidized cell membranes, but aiPLA2
assay in vitro indicates that, unlike assay at pH 4, activity at cytosolic pH is essentially absent
with non-oxidized substrate. However, the addition of glutathione (GSH) to the assay medium
significantly increased aiPLA2 activity at cytosolic pH, while oxidized GSH (GSSG) and several other
thiols had no effect. By mass spectroscopy (ESI MS), the addition of GSH to Prdx6 paradoxically led
to oxidation of its conserved Cys47 residue to a sulfinic acid. The effect of GSH on PLA2 activity
was abolished by incubation under anaerobic conditions, confirming that auto-oxidation of the
protein was the mechanism for the GSH effect. Analysis by circular dichroism (CD) and tryptophan
fluorescence showed alterations of the protein structure in the presence of GSH. Independently
of GSH, the oxidation of Prdx6 by exposure to H2O2 or the presence of oxidized phospholipid as
substrate also significantly increased aiPLA2 activity at pH 7. We conclude that the oxidation of the
peroxidatically active Cys47 of Prdx6 results in an increase of aiPLA2 activity at pH 7 without effect
on the activity of the enzyme at pH 4.
Keywords: substrate binding; sulfinic acid; Prdx6 structure; mass spectroscopic analysis
1. Introduction
Peroxiredoxins (Prdxs) are a widely distributed family of antioxidant enzymes that use a cysteine
thiol group as a catalytic center to catalyze the reduction of hydroperoxides [1]. These enzymes function
in anti-oxidant defense and they also have an important role in cell signaling through the regulation
or sensing of local peroxide concentration [2]. The mammalian peroxiredoxin (Prdx) family consists
of six members with a common mechanism for their peroxidase activity. The three-step peroxidatic
cycle for the Prdx proteins involves: (i) reduction of a hydroperoxide substrate through the oxidation
of a catalytic Cys to a sulfenic acid, followed by; (ii) formation of a disulfide; and, (iii) reduction of
the disulfide to regenerate the active protein. The last mammalian peroxiredoxin to be described was
Prdx6, a protein that is expressed in essentially all tissues but at particularly high levels in lung, brain,
eye, and testes [3–5]. While Prdx6 is similar to Prdxs 1–5 in its use of a catalytic Cys residue (C47 in
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Prdx6) to reduce H2O2, short chain hydroperoxides, and peroxynitrite (step i above) [6,7], it expresses
several unique features that distinguish it from other Prdx family members.
A major difference between Prdx6 and Prdxs 1–5 relates to both steps (ii) and (iii) (the resolution
phases) of the peroxidatic catalytic cycle. These steps in the cycle are accomplished in Prdxs 1–5 by
a Cys that is intrinsic to the protein (called the resolving Cys), followed by reduction of the disulfide
with thioredoxin [3]. On the other hand, Prdx6 uses glutathione (GSH) catalyzed by GSH S-transferase
(GST) to complete the reaction cycle [8–10]. Based on the characteristics of the catalytic mechanism
reflecting the number of conserved cysteine residues, Prdxs 1–5 have been called 2-Cys enzymes.
While Prdx6 has been called 1-Cys Prdx. Another important difference between Prdx6 and other family
members is that Prdx6, unlike Prdx 1–5, has the ability to reduce phospholipid hydroperoxides with
a rate constant similar to that for the reduction of H2O2 (∼106 M−1 s−1) [9,11].
In addition to differences in the peroxidatic reaction cycle and importantly for this manuscript,
Prdx6 expresses several enzymatic functions that are not expressed by Prdxs 1–5. One of these
enzymatic functions of Prdx6 is a phospholipase A2 (PLA2) activity. This latter activity is not associated
with C47 but is based on an enzymatically active site consisting of a Ser-His-Asp catalytic triad [12].
Finally, Prdx6 has a third enzymatic activity that is based on a HxxxxD active site (spanning the amino
acids 26–31) that catalyzes lysophosphatidylcholine acyl transferase activity (LPCAT) [13]. Thus, Prdx6
appears to play a unique role in phospholipid metabolism with the ability to catabolize (PLA2 activity)
and/or remodel phospholipids (LPCAT activity) as well as to maintain these phospholipids in their
reduced state (peroxidase activity). Regulation of the PLA2 activity of Prdx6 is the major focus of
this mms.
Our initial reports describing Prdx6-PLA2 activity indicated that the enzyme is active at acidic pH
(pH 4), but it has relatively little activity at neutral pH and above [8]. This enzymatic activity at acidic
pH is consistent with the localization of the protein to acidic organelles, such as lung lamellar bodies
and lysosomes, where it plays an important role in phospholipid turnover [6,14]. Thus, when first
described, the enzyme was given the trivial name acidic, Ca2+ independent PLA2 (aiPLA2) to reflect its
acidic pH requirement for catalysis and its catalytic activity in the absence of Ca2+ [15,16]. However,
subsequent studies have indicated that the PLA2 activity of Prdx6 also plays important roles in
the repair of peroxidized cell membranes [17,18], as well as in the activation of NADPH oxidase
(type 2) [19,20], functions that presumably require PLA2 activity in the cytosol at approximately
neutral pH. This requirement can be accomplished by several mechanisms. First, phosphorylation of
the protein results in a markedly increased activity at pH 7–8 (as well as at acidic pH) [21]; we have
shown that conformational change of Prdx6 upon its phosphorylation is the basis for the enhancement
of substrate binding and increased PLA2 enzymatic activity [22]. Second, the presence of an oxidized
substrate, e.g., a phospholipid hydroperoxide, significantly enhanced enzymatic activity at neutral
pH [23]. As a third mechanism, oxidation of the conserved C47 of Prdx6 following the treatment of
cells with H2O2 resulted in increased PLA2 activity at neutral pH [24].
An additional mechanism that results in increased Prdx6-PLA2 activity at pH 7 was discovered by
serendipity. As described above, GSH is required for Prdx6 peroxidase activity; it is commonly used as
a reactant in a peroxidase activity assay that is routinely carried out at pH 7 [9]. During our use of this
assay, we identified products in the incubation medium that appeared to reflect the presence of PLA2
activity and postulated that this might have been due to the presence of GSH. Further study indicated
that GSH did indeed stimulate Prdx6-PLA2 activity at pH 7, while there was no effect on activity
at pH 4 [25]. The present study was undertaken to document this result and to evaluate a possible
mechanism for this effect of GSH. This publication is part of a forum on Peroxiredoxin 6 as a Unique
Member of the Peroxiredoxin Family.
Antioxidants 2019, 8, 4 3 of 14
2. Materials and Methods
2.1. Reagents
1,2-Bis palmitoyl-sn-glycero-3-phosphocholine (DPPC), egg yolk phosphatidylcholine
(PC), phosphatidylglycerol (PG), 1-palmitoyl-2-linoleoyl-sn-glycero-3-phosphocholine (PLPC),
phosphatidylserine (PS), and cholesterol (chol) were purchased from Avanti-Polar Lipids (Birmingham,
AL). Extracellular-signal-regulated kinase (Erk2) was purchased from Upstate (Millipore, Billerica,
MA, USA). Protein concentration was measured by Coomassie blue binding using bovine γ-globulin
as the standard (Bio-Rad, Hercules, CA, USA). A mouse monoclonal antibody against human
Prdx6 was purchased from Chemicon EMD Millipore (Billerica, MA, USA). Bromoenol lactone
(BEL) was obtained from Cayman Chemical (Ann Arbor, MI, USA). Reduced glutathione (GSH),
oxidized glutathione (GSSG), MJ33 (1-hexadecyl- 3-trifluoroethylglycero -sn-2-phosphomethanol),
tris (2-carboxyethyl) phosphine (TCEP), dithiothreitol (DTT), and all other chemicals were purchased
from Sigma-Aldrich (St. Louis, MO, USA).
2.2. Production of Recombinant Prdx6
The expression of human codon optimized Prdx6 plasmid pJexpress 414:75271—prdx6-optEc
in Escherichia coli BL21 (DE3) (Novagen, Madison, WI, USA) has been described previously [25].
The purification and identification of recombinant human Prdx6 protein was carried out by the
modification of previously described methods for isolation of the rat and human proteins [10,22,23,26].
Purification of recombinant Prdx6 by chromatography utilized an ion exchange diethylaminoethyl
(DEAE) column in a fast protein liquid chromatography (FPLC) AKTA purifier system controlled by
Unicon 5.1 software (GE Healthcare Biosciences, Uppsala, Sweden). The column was equilibrated with
40 mM Na-acetate buffer (pH 5) containing 1 mM ethylenediaminetetraacetic acid (EDTA), 3% glycerol,
and 1 mM TCEP. Since the isoelectric point for Prdx6 is ∼6.0, it does not bind to positively charged
DEAE resin at pH 5 and the Prdx6 protein was collected from the flow-through. (The column was
rejuvenated by eluting bound (non-Prdx6) proteins using a high salt solution (40 mM Na-acetate,
2 M NaCl, 1 mM EDTA, 3% glycerol, 1 mM TCEP, pH 5) (see Supplemental Figure S1). The purified
Prdx6 fraction was concentrated using a 10 kDa molecular mass cut-off Amicon Ultra filter (Millipore,
Billerica, MA, USA) followed by dialysis against 50 mM Tris-HCl buffer (pH 8) containing 1 mM EDTA,
3% glycerol, and 1 mM TCEP with a 10 kDa molecular mass cut-off Slide-A-Lyzer®dialysis cassette
(Pierce, Rockford, IL, USA). The preparation was evaluated by polyacrylamide gel electrophoresis
(PAGE) stained with Coomassie blue (see Supplemental Figure S1). Immunoblots with monoclonal
anti-Prdx6 as the primary and goat anti-mouse IgG as the secondary antibody were used to confirm the
presence of Prdx6 in the purified protein preparation; the blots were analyzed and the purity in each
band was calculated by the two-color Odyssey technique (LI-COR, Lincoln, NE, USA) [26]. The protein
was stored at −80 ◦C before use. For some studies, Prdx6 was phosphorylated by incubation with
ERK2 in the presence of ATP and MgCl2, as described previously [22] or oxidized by treating the
purified protein with 100 µM H2O2 for 15 min.
2.3. Measurement of aiPLA2 Activity
The measurement of Prdx6-PLA2 (aiPLA2) activity has been described previously [4,12,15,16].
A liposomal preparation of lipids reflecting the composition of lung surfactant was used as the substrate
for the assay. The lipid mixture contained DPPC, PC, Chol, and PG in the molar ratio 50:25:15:10;
liposomes were labeled with tracer [3H-9,10-palmitate]-DPPC in the sn-2 position. This substrate was
used for all assays, unless a different substrate is specifically indicated. Lipids that were dissolved
in chloroform were evaporated to dryness under N2 onto the wall of a Corex glass centrifuge tube;
the evaporated film was resuspended in 50 mM Tris-HCl in phosphate-buffered saline (PBS), pH 7.4,
vigorously mixed, frozen, and thawed three times by alternating liquid N2 and a 50 ◦C water bath, and
then extruded under pressure at 50 ◦C for 10 cycles through a 0.1 µm pore size polycarbonate filter.
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Recovery of 3H in the liposome preparation was >95% of the original disintegrations per min (DPMs)
that were added to the lipid mixture. Analysis with a dynamic light scattering (DLS) 90 Plus Particle
size Analyzer (Brookhaven Instruments, Holtsville, NY, USA) showed a homogeneous population
of unilamellar vesicles with a diameter of 100–120 nm. Liposomes were stored overnight at 4 ◦C
before use.
In experiments, to study the role of an oxidized phospholipid substrate, oxidizable liposomes
were generated with PLPC substituting for egg PC in the standard liposomes. These liposomes
were exposed to an •OH-generating system (10 µM Cu2+ in the presence of 0.2 mM ascorbate) [27]
for 45 min at room temperature. The liposomes were dialyzed for 2 h against PBS (pH 7.4) using
a Slide-A-Lyzer®dialysis cassette as above. These liposomes presumably contained PLPCOOH as
an oxidized lipid component.
To measure PLA2 activity, enzyme (Prdx6) in buffer (Tris-EGTA, pH 7.4) was pre-incubated for
15 min and the reaction was started by addition of substrate (3H-labeled liposomes) for a 1 h incubation.
Lipids were then extracted from the liposomal suspension, separated by thin layer chromatography
(TLC), and the free fatty acid band was analyzed by scintillation counting. PLA2 activity was calculated
from the liberation of 3H-palmitic acid.
To measure PLA2 activity under anaerobic conditions, the incubation medium first was purged of
air in an N-EVAP (Organomation Assoc., Northborough, MA, USA) using a continuous flow of 100%
N2 for 10 min; N2 flow then was maintained during the pre-incubation and incubation periods.
2.4. Mass Spectroscopy (ESI- MS and LC-MS/MS)
Both hPrdx6 WT and hPrdx6 C91S were gel-filtered using two Superdex 75 (GE Healthcare,
Chicago, IL, USA) columns that were connected in series and equilibrated in 10 mM Tris, 100 mM
NaCl, pH 7.4 (TBS), and maintained at 4 ◦C. Each sample was diluted to 0.55 mg/mL in TBS, with or
without addition of 5 mM GSH (final concentration), pH 7.4. Samples were incubated for 1 h at
37 ◦C, and then stored at 0 ◦C. After 16–20 h of storage, TCEP (5 mM final concentration) was added
to half of each sample. The samples were incubated for 30 min at 37 ◦C and then stored on ice
until analysis by electrospray ionization mass spectrometry (ESI MS). Prior to injection onto the
liquid chromatography-mass spectroscopy (LC-MS) system, samples were diluted to 0.1 mg/mL.
A Dionex C4 Trap column and a self packed Poros C8 analytical column (20 cm) were interfaced
directly with an Orbitrap XL operating at 100 K resolution. Thermo Xtract software (Thermo Fisher
Scientific, Waltham, MA, USA) was used for deconvolution of the monoisotopic masses. A portion
of each sample was alkylated with iodoacetamide, followed by denaturation with urea, reduction
with DTT, and then alkylation with acrylamide. Samples were digested with trypsin and analyzed
using liquid chromatography-tandem mass spectrometry (LC-MS/MS) using an LTQ-Orbitrap XL™
mass spectrometer (Thermo Fisher Scientific Waltham, MA, USA). Data was searched using MaxQuant
software (Max Planck Institute of biochemistry, München, Germay). The following cysteine mass
modifications were included in the search: iodoacetamide derivative, 57.0215 Da; acrylamide adduct,
71.0371 Da; 2 oxidations, 31.9898 Da; 3 oxidations, 47.9847 Da. The intensity value from the MaxQuant
output files for the variable modified cysteine containing peptides DFTPVCTTELGR (C47) and
DINAYNCEEPTEK (C91) were plotted with the Excel program to show the relative quantitation
for each peptide that was obtained after treatment of the protein with the different buffer conditions.
2.5. Fluorescence Spectroscopy
Fluorescence spectroscopy was performed with a spectrofluorometer (PTI, Photon Technology
International, Lawrenceville, NJ, USA) equipped with a water bath temperature-controlled sample
holder, a single-photon counting system for fluorescence intensity detection, and dual fluorescence
and absorbance channels. Measurements were performed with 1 µM protein at 22 ◦C in microquartz
fluorescence cuvettes with a path length of 0.3 cm. Fluorescence was excited at 295 nm and recorded
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in the range of 310–450 nm (the emission spectrum of tryptophan) with a 1 nm slit width for both
excitation and emission.
2.6. Circular Dichroism (CD)
Prdx6 (6.5 µM in 10 mM Tris buffer, pH 7) was analyzed for CD in a fused quartz cell with
a path length of 0.1 cm using a Chirascan™ CD Spectrometer (Applied Photophysics Ltd. Surrey, UK).
Protein with or without GSH or GSSG (5 mM) was incubated for 1 h at room temperature in 10 mM
Tris buffer, pH 7. Spectra were recorded with three repeats in the far-ultraviolet region (190–260 nm)
with a bandwidth of 1.0 nm, a step size of 0.5 nm, and an integration time of 30 s.
2.7. Statistical Analysis
Data are expressed as means ± standard error (SE). Differences between mean values were
analyzed by two-tailed Student’s t test and they were considered statistically significant at p < 0.05.
3. Results
3.1. Effect of GSH on the PLA2 Activity of Prdx6
The PLA2 activity of recombinant human Prdx6 measured at pH 4 was ~100 nmol/min/mg
protein (not shown), but it was <1 nmol/min/mg protein when measured at pH 7.4 using the standard
liposomal (non-oxidized) substrate described in Methods (Table 1). The addition of GSH (5 mM) to
the incubation medium had no effect on aiPLA2 activity at pH 4 (not shown) but increased activity
at pH 7.4 to ~50% of the pH 4 value (Table 1). The stimulation of aiPLA2 activity by GSH was seen
at pH > 5 (Figure 1). Stimulation of activity was dependent on GSH concentration with maximal
effect at 3 mM GSH (Figure 1). GSH-stimulated activity was sensitive to MJ33, a known inhibitor
of aiPLA2 activity, while BEL, an inhibitor of some intracellular, Ca2+ independent PLA2 enzymes,
was ineffective (Table 1). The addition of oxidized GSH (GSSG) or the unrelated thiols, DTT, or TCEP,
to the assay resulted in a relatively minor increase in aiPLA2 activity that was not statistically different
from control (Table 1).
Table 1. Effect of protein and substrate modifications on phospholipase A2 (PLA2) activity of
peroxiredoxin 6 (Prdx6) at pH 7.4.
Condition PLA2 Activity at pH 7.4nmol/min/mg
−GSH +GSH
Control 0.3 ± 0.06 (6) 51 ± 1 (6)
+MJ33 ___ 19 ± 2* (3)
+BEL ___ 50 ± 1 (4)
+GSSG 3.2 ± 2.1 (3) __
+DTT 2.0 ± 1.4 (3) __
+TCEP 0.5 ± 0.1 (3) __
Anaerobic 0.2 ± 0.1 (4) 0.2 ± 0.1* (4)
Liposomes with PLPC† 0.3 ± 0.02 (6) 48 ± 1 (6)
Oxidized liposomes with PLPC† 100 ± 1* (3) 100 ± 1* (3)
Phosphorylated Prdx6 1220 ± 6* (3) 1150 ± 3* (3)
Oxidized Prdx6 100 ± 3* (3) 99 ± 1* (3)
Human Prdx6 (2 µg) was pre-incubated with reagents for 15 min and then PLA2 activity was measured at pH 7.4 in
Ca2+ free buffer. Substrate was 3H-1,2-Bis palmitoyl-sn-glycero-3-phosphocholine (DPPC) in mixed unilamellar
liposomes. When added, glutathione (GSH) and other sulfhydryls were at 5 mM, MJ33 at 3 mol% of lipid, and BEL
at 0.1 mM. Prdx6 was oxidized with H2O2 or was phosphorylated with Erk2. Values are mean ± SE for the
number of experiments indicated in parentheses. * Significantly different (p < 0.05) from corresponding control
(plus or minus GSH). † Liposomes with 1-palmitoyl, 2-linoleoyl, sn-glycero-3-phosphocholine (PLPC) replacing egg
phosphatidylcholine (PC).
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Figure 1. Glutathione (GSH) stimulates the PLA2 activity of Prdx6. (A). pH-dependence for the effect
of GSH. GSH concentration was 5 mM. (B). Effect of GSH concentration on the stimulation of PLA2
activity. The effect of GSH is maximal at 3 mM.
The basal activity and stimulation of activity by GSH at pH 7.4 was similar for control liposomes
(DPPC as substrate) and liposomes containing linoleoyl in the sn-2 position of PC (PLPC) as
the substrate for the PLA2 reaction (Table 1). As reported previously, aiPLA2 activity at pH 7.4
with oxidized PLPC (i.e., PLPCOOH) as the liposomal substrate was significantly increased when
compared to control [17,23] and it was increased to a much greater extent with the phosphorylation of
Prdx6 [21,22]. Oxidation of the Prdx6 protein increased its aiPLA2 activity with reduced substrate to
the same level as with oxidized liposomes. Activity with PLPCOOH substrate, phosphorylated Prdx6,
or with oxidized Prdx6 was not increased further in the presence of GSH (Table 1).
3.2. Molecular O2 is Required for Generation of the Sulfinic Prdx6
We postulated that the generation of the sulfinic form of Prdx6 in the presence of GSH represented
auto-oxidation of the sulfenic form of the protein. To test this hypothesis, the assay for aiPLA2 activity
was carried out under anaerobic conditions. The aiPLA2 activity of the protein was markedly inhibited
in the absence of O2 (Table 1). The failure of aiPLA2 activity to increase in the presence of GSH under
anaerobic conditions is compatible with a requirement of molecular oxygen for the oxidation of the
sulfenic Prdx6. It is likely that the actual oxidant under aerobic conditions is H2O2, generated from
molecular O2 in the presence of trace metals [28].
3.3. Prdx6 Modifications in the Presence of GSH Evaluated by ESI- MS and LC-MS/MS
The effect of GSH on the mass of Prdx6 as well as C91S-Prdx6 was determined using ESI MS
(Figure 2). C91 is a non-conserved Cys residue that is present in the human-derived Prdx6 protein
used in the present study but in most mammalian species, including rat, mouse and bovine Prdx6;
C47 is the lone Cys residue [6]. The conserved peroxidatic Cys (C47) also is the only Cys group that is
present in recombinant human C91S-Prdx6 protein. The observed monoisotopic mass for both Prdx6
and C91S-Prdx6 in Tris buffered saline (TBS) deviated by −2 Da from the predicted monoisotopic
mass of the sulfhydryl (Figure 2A), as we have published previously [26]. These results are consistent
with oxidation of the protein to the sulfenic form, followed by the loss of H2O and formation of
a sulfenylamide between the reactive Cys47 and an adjacent amino acid residue, possibly Thr48.
In the presence of TCEP, the sulfenylamide bond is reduced, yielding proteins with the expected
monoisotopic mass for Prdx6 and for C91S-Prdx6 (sulfhydryl forms).
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Figure 2. Electrospray ionization mass spectrometry (ESI MS) of wild type and C91S Prdx6. (A) upper
4 panels). Effect of tris (2-carboxyethyl) phosphine (TCEP) on protein mass. The addition of TCEP
resulted in an increase of 2 Da in molecular mass of both wild type and C47S-Prdx6. (B) lower 4 panels).
Effect of glutathione (GSH) +/- TCEP on protein mass. The addition of GSH resulted in a mass increase
of 34 Da; there was no further effect with addition of TCEP in the presence of GSH. TBS. tris-buffered
saline. A and B were part of the same experiment; A, but not B, was published previously [26] and it is
reprinted with permission.
In the presence of GSH added to Prdx6 in TBS solution, the molecular mass of the protein increased
to 24,920, a gain of 34 Da (Figure 2B). Our interpretation of this result is that the addition of GSH
leads to reversal of the sulfenylamide to reform the sulfenic (+18 mass increase) and the subsequent
oxidation of the sulfenic to sulfinic with the addition of an oxygen atom (+16 Da mass increase)
accounts for the total increase in mass. A similar increase in mass of 34 Da in the presence of GSH
was seen for C91S-Prdx6, indicating that the non-conserved Cys91 residue does not participate in the
reactions, leading to the change in mass. Thus, the C47 residue in the Prdx6 proteins is paradoxically
converted to a sulfinic acid (Cys-SOOH) in the presence of GSH; this sulfinic acid is not reduced by the
subsequent addition of TCEP (Figure 2B).
The formation of a sulfinic acid at Cys47 of Prdx6 was confirmed by alkylation of the cysteine
residues in Prdx6 with iodoacetamide, followed by denaturation, reduction, and alkylation with
acrylamide, trypsin digestion, and then analysis by liquid chromatography-tandem mass spectrometry
(LC-MS/MS) in order to determine the levels of reduced, accessible cysteine (see Supplemental
Figure S2). The presence of a sulfinic acid in the C47-containing digestion product of Prdx6
(i.e., the peptide DFTPVCTTELGR) was observed in the presence of GSH (with or without TCEP),
but sulfinic acid was not observed in the peptide containing C91 (i.e., the peptide DINAYNCEEPTEK).
3.4. GSH Induces Changes in Tryptophan Fluorescence and Circular Dichroism (CD) in hPrdx6
We examined potential changes in Prdx6 structure following the addition of GSH. Prdx6 has
three tryptophan residues, two of which are in close proximity to the enzymatically active sites for
peroxidase (C47) and PLA2 (S32) activities [12]. A change in tryptophan fluorescence is presumed to
reflect a change in the local environment of tryptophan residues in the protein [29]. The addition of
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GSH resulted in a decrease of fluorescence intensity (Figure 3), which is compatible with the exposure
of a tryptophan residue to a more polar environment [30]. There was no change in Trp fluorescence
following the addition of GSSG.
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Figure 3. Effect of glutathione (GSH) and oxidized GSH (GSSG) on trptophan fluorescence emission of
Prdx6 at pH 7. There is decreased fluorescence of Prdx6 in the presence of GSH while the presence of
GSSG had no effect.
The far UV circular dichroism (CD) profile of Prdx6 was also used to evaluate the effect of GSH
addition on protein structure. Ignoring the noise below 215 nm, the results show that GSH, but not
GSSG, induces a change in signal in the 210–240 nm region of the CD spectrum (Figure 4). This change
reflects a decrease in the α-helical content of Prdx6.
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3.5. PLA2 Activity with Protein Modification
The PLA2 activity of Prdx6 at pH 7.4 was increased by the oxidation of the protein through its
exposure to H2O2 (Table 1). This increase in activity at pH 7.4 with oxidized Prdx6 was about double
the GSH-induced increase that was seen with non-oxidized Prdx6. Activity at pH 4 with oxidized
Prdx6 was 102 ± 2 (n = 3), similar to the value at pH 7.4. There was no effect of GSH on aiPLA2 activity
with either the oxidized protein or the oxidized substrate at either pH.
As we have shown previously, phosphorylation of Prdx6 also results in a marked increase in its
aiPLA2 activity [22]. The increase in activity at pH 4 was ~20-fold and, fold-wise, was considerably
greater at pH 7.4 (Table 1), so that the resultant activities of phosphorylated Prdx6 were similar at
acidic and basic pHs [21,23]. This increased activity with Prdx6 phosphorylation greatly exceeded the
increase in activity with Prdx6 oxidation.
4. Discussion
The major finding of the present study was that the addition of GSH to the medium that was used
for assay of the PLA2 activity of Prdx6 resulted in: a) a physical change of protein structure, as shown
by tryptophan fluorescence and far UV circular dichroism; b) the irreversible oxidation of the protein
to the sulfinic acid (as indicated by MS analysis); and, c) an increase of its PLA2 activity at neutral pH.
The increased aiPLA2 activity in the presence of GSH was inhibited by MJ33, a mimic of the enzymatic
transition state for some PLA2 enzymes and a known inhibitor of aiPLA2 activity [31,32]. These results
provide evidence that the catalytic mechanisms for stimulated PLA2 activity at pH 7 and basal activity
at pH 4 are similar. Stimulation aiPLA2 activity at pH 7 appeared to be specific for GSH, since other
sulfhydryls (GSSG, DTT, TCEP) were ineffective. Based on these results that confirmed a previous
report [24], we conclude that GSH exerts its stimulatory effect on aiPLA2 activity through oxidation of
the protein (Prdx6).
Although this effect of GSH to promote Prdx6 oxidation initially was surprising, since GSH is
a mild reductant, further consideration led us to propose the following mechanism. Based on the
MS analysis, recombinant Prdx6 after purification and storage was oxidized to the sulfenylamide,
a form that has been shown to “protect” some proteins against further auto-oxidation [33]; in the case
of Prdx6, the auto-oxidizable site is C47, the active site for peroxidase activity. The Prdx6 sulfenylamide
is formed by the oxidation of the thiol to the sulfenyl that rapidly reacts with an adjacent amine in
the protein to form the stable sulfenylamide [25]; the specific amino group that was involved in this
reaction has not yet been determined. The mechanism for auto-oxidation has been shown to reflect
primarily the presence of trace metals [28,34,35]. In the presence of TCEP, the sulfenylamide state of
the protein can be reversed first to the sulfenic and then reduced to the sulfhydryl; auto-oxidation
of the protein under these conditions is prevented by the presence of the strong reductant (TCEP).
GSH also is able to reverse sulfenylamide formation, as shown in previous studies with the enzyme
protein tyrosine phosphatase B1 (PTPB1) [36]. This reversal reaction likely proceeds through the
formation of a disulfide between GSH and the sulfenylamide to form a glutathionylated protein
followed by hydrolysis to regenerate the sulfenyl [28]. However, GSH is a relatively weak reductant
that cannot, by itself, reduce the sulfenic [3,10], and therefore cannot protect the protein against
further oxidation to the sulfinic (and possibly sulfonic) form. Under physiological conditions in vivo,
catalysis by glutathione S-transferase (GST) in the presence of GSH regenerates the sulfhydryl, thereby
preventing its irreversible oxidation [10,37,38]. However, with severe oxidative stress or with GST
deficiency, oxidation of Prdx6 could occur in vivo, resulting in a significant increase of intracellular
aiPLA2 activity. It is important to note that this increase in aiPLA2 activity would be accompanied by
loss of the GSH peroxidase activity of Prdx6 due to irreversible inactivation of the catalytic Cys 47.
The reactions of Prdx6 that occur in vitro in the absence of GST are shown in Figure 5.
To summarize these reactions, exposure of the protein to air during the isolation and storage of
recombinant Prdx6 results in the oxidation of the thiol to an unstable sulfenylated protein that rapidly
dehydrates to a stable sulfenylamide (reactions 1 and 2). The oxidant (shown as H2O2 in the figure) is
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generated from atmospheric O2 in the presence of trace metals [27,34,35]. Following the addition of
GSH, there is regeneration of the sulfenic protein (reactions 3 and 4). In the presence of GSH, the rate of
H2O2 generation through metal-catalyzed auto-oxidation is greatly increased [34], and the sulfenic can
be oxidized to the sulfinic form (reaction 5). The irreversible formation of the sulfinic in the presence of
GSH pulls the reaction cycle toward oxidation. Thus, the end result is Prdx6 over-oxidation following
the addition of GSH to the protein in vitro, in the absence of GST. Under physiologic conditions in the
presence of cellular GST plus GSH, the heterodimerization of Prdx6 with GST leads to a reduction of
Prdx6 to the native sulfhydryl (reactions not shown) [26].
 
2 
 
Figure 5. Reactions of Prdx6 with GSH in vitro. Reactions 1 and 2 occur during isolation of Prdx6
in the absence of GSH and GST; auto-oxidation of the protein by oxidant generation (shown here as
HOOH) in the presence of trace metals leads to the formation of the Prdx6 sulfenic acid (reaction 1)
and then dehydration to form the sulfenylamide (reaction 2). Reaction 2 is rapid when compared to
the relatively slow rate of H2O2 formation (reaction 5 in the absence of GSH). Reactions 3 and 4 occur
in vitro following the addition of GSH in the absence of GST. The sulfenylamide is reversed through
glutathionylation of the protein (reaction 3), followed by reformation of the sulfenic acid (reaction 4).
The rate of H2O2 generation is greatly enhanced in the presence of GSH [34], resulting in the oxidation
of the sulfenic to the sulfinic (reaction 5 in the presence of GSH).
Similarly to the effect of GSH addition to the assay medium, oxidation of the protein by treatment
with H2O2 prior to the assay also resulted in increased PLA2 activity (Table 1). A similar result was
reported previously that used mutagenesis to show that the increase of activity with H2O2 treatment
required the presence of C47 in Prdx6 [24]. aiPLA2 activity in the present study also was increased
in the presence of a peroxidized lipid substrate (PLPCOOH), confirming our previous report [23].
Thus, several different reactions demonstrate a similar mechanism to stimulate aiPLA2 activity in vitro,
namely the oxidation of the conserved Cys of Prdx6. These oxidative reactions include: (1) the presence
of GSH; (2) pretreatment of the enzyme with H2O2; or, (3) use of PLPCOOH as the liposomal substrate.
Each of these assay conditions in the absence of GST would be expected to result in the oxidation of
the C47 of Prdx6.
These findings reflect on the catalytic cycle for peroxidase activity. The reaction of H2O2 or
a hydroperoxide substrate with Prdx6 will result in the formation of a sulfenic acid intermediate as the
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first step in the reduction of the oxidized lipid through peroxidase catalysis. In the absence of GST,
the reaction cycle cannot be completed and the sulfenyl protein is susceptible to further oxidation,
as shown previously using specific antibodies for the over-oxidized state of Prdx6 [23]. The presence
of GST plus GSH prevents over-oxidation and it returns Prdx6 to its native sulhydryl form, thereby
completing the peroxidase reaction cycle and preserving its peroxidase function.
Nevertheless, how does Cys oxidation affect aiPLA2 activity since the C47 residue in Prdx6,
while being crucial for its peroxidatic function, has no direct role in the PLA2 reaction? Although
our previous studies have shown that reduced (non-oxidized) phospholipid substrate does not bind
at pH 7, it does bind to Prdx6 at pH 4; on the other hand, oxidized phospholipids bind to Prdx6
equally at acidic and neutral pH [23]. C47 is present as a thiolate at pH 7, but it is protonated to
a sulfhydryl at pH 4, possibly resulting in changes in structure that facilitate the binding of substrate [2].
These binding data directly correlate with aiPLA2 activity. Binding of reduced substrate at pH 4 results
in PLA2 activity, while binding of an oxidized phospholipid at pH 7 can result in PLA2 as well as
peroxidase activity.
Crystal structure analysis has provided some insights into substrate binding [39]. The crystal
structure of the sulfenic protein shows that the active site for Prdx6 binding (and aiPLA2-mediated
catalysis) is on the protein surface and it is connected to the peroxidatic site by a narrow pocket.
We have postulated that the oxidized phospholipid substrate is positioned for activity by binding of
the head group to the protein surface and the insertion of the oxidized sn-2 fatty acid chain inside of
the pocket [12]. On the other hand, crystal structural analysis of oxidized (sulfinic) Prdx6 indicates
almost 10 angstroms distance between the H26 and S32 sites that were proposed for phospholipid
binding. Because of this relatively long distance, it was suggested that the phospholipid actually
may bind to the flat surface across the PLA2 active site and the peroxidatic active site of the other
monomer [40]. However, several factors may modify the protein structure and its interaction with
substrate. For example, over-oxidation of C47 to the sulfinic alters the Prdx6 secondary structure,
as shown by CD analysis in this report. Further, the oxidation of C47 results in decreased affinity
for homodimerization of the protein, resulting in an increased tendency for monomer formation [26].
Finally, phosphorylation (at T177) may lead to structural changes that alter the distance between
the crucial amino acids [22]. We have shown, while using a zero-length chemical cross-linking and
homology methodology, that several regions of reduced human PRDX6 are in a substantially different
conformation from that shown for the crystal structure of the peroxidase catalytic intermediate [41].
Thus, the protein shows considerable plasticity and it can change conformation depending on many
variables that could affect Prdx6-substrate interactions. The variable states of Prdx6 require further
study before making definitive conclusions concerning the site and mechanism for binding of the
phospholipid substrate to the enzyme.
5. Conclusions
Isolated recombinant human Prdx6 undergoing auto-oxidation to the sulfenic can form
a sulfenylamide, a protected state that prevents auto-oxidation. The addition of GSH results in the
regeneration of the sulfenic form that can be irreversibly oxidized to the sulfinic by oxidants that are
produced through metal catalyzed auto-oxidation; the generation of oxidants through auto-oxidation
occurs at a significantly increased rate in the presence of GSH. Over-oxidation of Prdx6 to the sulfinic
results in a marked increase of its aiPLA2 activity at neutral pH, as shown previously [24] and in
this manuscript.
Supplementary Materials: The following are available online at http://www.mdpi.com/2076-3921/8/1/4/s1,
Figure S1: Purification of codon optimized recombinant human Prdx6 with an ion-exchange (DEAE cellulose)
column, Figure S2: Relative quantitation based on the intensity of modified peptides from LC-MS/MS data
analysis after treatment with GSH (+/−TCEP).
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